Karen A. Foster Biolife Solutions Inc (BLFS) insider trading activity

Karen A. Foster is Chief Quality and Operations of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 157,568 shares of BLFS, which is worth approximately $3.69 Million. The most recent transaction as insider was on Jun 21, 2021, when has been sold 16,332 shares (Common Stock) at a price of $1.64 per share, resulting in proceeds of $26,784. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K

0.23% 3M change

25.7% 12M change

Total Value Held $3.69 Million

Karen A. Foster Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 21 2021	BUY Exercise of conversion of derivative security	$26,784 $1.64 p/Share	16,332 Added 15.4%	89,716 Common Stock
May 28 2021	SELL Open market or private sale	$8,942 $33.87 p/Share	264 Reduced 0.36%	73,384 Common Stock
May 24 2021	SELL Open market or private sale	$513,478 $31.44 p/Share	16,332 Reduced 18.15%	73,648 Common Stock
May 24 2021	BUY Exercise of conversion of derivative security	$26,784 $1.64 p/Share	16,332 Added 15.36%	89,980 Common Stock
Apr 19 2021	SELL Open market or private sale	$532,097 $32.58 p/Share	16,332 Reduced 18.15%	73,648 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$26,784 $1.64 p/Share	16,332 Added 15.36%	89,980 Common Stock
Apr 12 2021	BUY Grant, award, or other acquisition	-	2,854 Added 3.73%	73,648 Common Stock
Apr 01 2021	SELL Open market or private sale	$124,713 $36.53 p/Share	3,414 Reduced 4.6%	70,794 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	-	8,797 Added 10.6%	74,208 Common Stock
Mar 26 2021	SELL Open market or private sale	$89,696 $35.01 p/Share	2,562 Reduced 3.77%	65,411 Common Stock
Mar 22 2021	SELL Open market or private sale	$613,430 $37.56 p/Share	16,332 Reduced 19.37%	67,973 Common Stock
Mar 22 2021	BUY Exercise of conversion of derivative security	$26,784 $1.64 p/Share	16,332 Added 16.23%	84,305 Common Stock
Feb 26 2021	SELL Open market or private sale	$11,238 $39.57 p/Share	284 Reduced 0.42%	67,973 Common Stock
Feb 22 2021	SELL Open market or private sale	$647,806 $39.66 p/Share	16,334 Reduced 19.31%	68,257 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	$26,788 $1.64 p/Share	16,334 Added 16.18%	84,591 Common Stock
Feb 19 2021	SELL Open market or private sale	$136,301 $40.76 p/Share	3,344 Reduced 4.67%	68,257 Common Stock
Feb 18 2021	SELL Open market or private sale	$136,367 $40.67 p/Share	3,353 Reduced 4.47%	71,601 Common Stock
Feb 17 2021	SELL Open market or private sale	$136,326 $41.55 p/Share	3,281 Reduced 4.19%	74,954 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	-	23,336 Added 22.98%	78,235 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	4,157 Added 7.04%	54,899 Common Stock
Dec 01 2020	SELL Open market or private sale	$5,891 $35.49 p/Share	166 Reduced 0.33%	50,742 Common Stock
Sep 29 2020	SELL Open market or private sale	$27,972 $28.63 p/Share	977 Reduced 1.88%	50,908 Common Stock

KAF

Karen A. Foster

Chief Quality and Operations

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account